All In Biotech

Free tool

FAERS Monitor: Tremfya

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761061 or its brand name (Tremfya, Guselkumab). Reports on generic versions are filed under their own applications.

Reports

38,224

Serious

9,624

25% of reports

Hospitalization

2,874

Death reported

482

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product dose omission issue12,395
  • accidental exposure to product3,707
  • drug ineffective2,587
  • needle issue2,480
  • psoriasis2,311
  • device issue2,150
  • device deployment issue1,793
  • device malfunction1,772
  • off label use1,650
  • product storage error1,218
  • device defective1,207
  • inappropriate schedule of product administration1,118
  • arthralgia1,040
  • device leakage1,010
  • product leakage993

Reports by year received

View as table
YearReports
20162
201784
20181,199
20192,087
20202,193
20213,115
20225,058
20235,778
20245,014
20256,820
20266,874

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,015,935 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product leakageSignal993133.8124.9105,195
device deployment issueSignal1,79389.785.4135,170
needle issueSignal2,48051.149.1111,656
device defectiveSignal1,20741.138.843,947
product dose omission issueSignal12,39524.223.8267,423
accidental exposure to productSignal3,70720.519.966,575
device malfunctionSignal1,77214.213.621,268
device issueSignal2,15013.512.924,360
device leakageSignal1,01013.112.311,036
psoriasisSignal2,3119.99.518,254
product storage errorSignal1,2187.77.37,084
inappropriate schedule of product administrationSignal1,1183.43.21,925
arthralgia1,0401.41.3109
drug ineffective2,5871.11.016
off label use1,6501.01.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.